{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Daytona Beach",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80750",
      "recalling_firm": "Product Quest Manufacturing LLC",
      "address_1": "330 Carswell Ave",
      "address_2": "N/A",
      "postal_code": "32117-4416",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0077-2019",
      "product_description": "Rexall, Extra Moisturizing No Drip Nasal Spray (Oxymetazoline Hydrochloride 0.05%) 1 FL OZ (30 mL) bottle, 48/3/1 #12687901 w/ Silo",
      "product_quantity": "Unknown",
      "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.",
      "recall_initiation_date": "20180803",
      "center_classification_date": "20181016",
      "termination_date": "20210330",
      "report_date": "20181024",
      "code_info": "All lots remaining within expiry."
    }
  ]
}